blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4219744

EP4219744 - METHODS OF PREPARING NUCLEIC ACIDS FOR SEQUENCING [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  01.03.2024
Database last updated on 13.09.2024
FormerThe application has been published
Status updated on  30.06.2023
Most recent event   Tooltip29.05.2024New entry: Decision on request for further processing 
Applicant(s)For all designated states
The General Hospital Corporation
55 Fruit Street
Boston, MA 02114 / US
For all designated states
ArcherDX, LLC
1400 16th Street
San Francisco, CA 91403 / US
[2023/31]
Inventor(s)01 / Iafrate, Anthony, John
Newton, 02465 / US
02 / Le, Long Phi
Charlestown, 02129 / US
03 / Zheng, Zongli
Boston, 02114 / US
04 / Myers, Jason
Boulder, 80301 / US
05 / Stahl, Joshua
Boulder, 80301 / US
 [2023/31]
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[2023/31]
Application number, filing date23152512.226.01.2015
[2023/31]
Priority number, dateUS201461931959P27.01.2014         Original published format: US 201461931959 P
[2023/31]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP4219744
Date:02.08.2023
Language:EN
[2023/31]
Type: A3 Search report 
No.:EP4219744
Date:30.08.2023
Language:EN
[2023/35]
Search report(s)(Supplementary) European search report - dispatched on:EP28.07.2023
ClassificationIPC:C12Q1/68, C12Q1/6806
[2023/35]
CPC:
C12Q1/6806 (EP,US); C12Q1/6809 (US)
C-Set:
C12Q1/6806, C12Q2535/122 (EP,US)
Former IPC [2023/31]C12Q1/68
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/14]
Former [2023/31]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:VERFAHREN ZUR HERSTELLUNG VON NUKLEINSÄUREN ZUR SEQUENZIERUNG[2023/31]
English:METHODS OF PREPARING NUCLEIC ACIDS FOR SEQUENCING[2023/31]
French:PROCÉDÉS DE PRÉPARATION D'ACIDES NUCLÉIQUES POUR LE SÉQUENÇAGE[2023/31]
Examination procedure28.02.2024Examination requested  [2024/14]
28.02.2024Date on which the examining division has become responsible
22.03.2024Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
20.05.2024Amendment by applicant (claims and/or description)
Parent application(s)   TooltipEP15740988.9  / EP3099820
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
20.05.2024Request for further processing filed
20.05.2024Full payment received (date of receipt of payment)
Request granted
28.05.2024Decision despatched
Fees paidRenewal fee
19.01.2023Renewal fee patent year 03
19.01.2023Renewal fee patent year 04
19.01.2023Renewal fee patent year 05
19.01.2023Renewal fee patent year 06
19.01.2023Renewal fee patent year 07
19.01.2023Renewal fee patent year 08
19.01.2023Renewal fee patent year 09
29.01.2024Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]AU2005203617  (NUGEN TECHNOLOGIES INC [US]) [A] 1-15 * page 55, lines 12-25; Fig. 6a and 6b *;
 [A]US2009203085  (KURN NURITH [US], et al) [A] 1-15 * Fig. 13, steps II and III *;
 [A]WO2012064739  (UNIV COLUMBIA [US], et al) [A] 1-15 * Fig. 3a and 3b *;
 [A]  - CALLAWAY A S ET AL, "A Sobemovirus coat protein gene complements long-distance movement of a coat protein-null Dianthovirus", VIRO, ELSEVIER, AMSTERDAM, NL, (20041205), vol. 330, no. 1, doi:10.1016/J.VIROL.2004.09.037, ISSN 0042-6822, pages 186 - 195, XP004620820 [A] 1-15 * par. bridging pages 192 and 193 *

DOI:   http://dx.doi.org/10.1016/j.virol.2004.09.037
 [I]  - ZHEN WANG ET AL, "Fusion primer and nested integrated PCR (FPNI-PCR): a new high-efficiency strategy for rapid chromosome walking or flanking sequence cloning", BMC BIOTECHNOLOGY, (20110101), vol. 11, no. 1, doi:10.1186/1472-6750-11-109, ISSN 1472-6750, page 109, XP055015224 [I] 1-15 * Fig. 1a; Fig. 2; page 11, left col.; last par. *

DOI:   http://dx.doi.org/10.1186/1472-6750-11-109
 [A]  - V. C. GOULD ET AL, "Analysis of sequence variation among smeDEF multi drug efflux pump genes and flanking DNA from defined 16S rRNA subgroups of clinical Stenotrophomonas maltophilia isolates", JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, (20040714), vol. 54, no. 2, doi:10.1093/jac/dkh367, pages 348 - 353, XP055428129 [A] 1-15 * page 349m "Polymerase chain reaction protocols" *

DOI:   http://dx.doi.org/10.1093/jac/dkh367
 [A]  - YAO-GUANG LIU ET AL, "High-efficiency thermal asymmetric interlaced PCR for amplification of unknown flanking sequences", BIOTECHNIQUES RAPID DISPATCHES, US, (20071101), vol. 43, no. 5, doi:10.2144/000112601, ISSN 0736-6205, pages 649 - 656, XP055428052 [A] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.2144/000112601
 [I]  - WANG ZHEN ET AL, "Supplementary data for: Zhen Wang; Shafei Ye; Jingjing Li; Bo Zheng; Manzhu Bao; Guogui Ning Fusion primer and nested integrated PCR (FPNI-PCR): a new high-efficiency strategy for rapid chromosome walking or flanking sequence cloning XP055015224", BMC BIOTECHNOLOGY, (20110101), vol. 11, no. 109, pages 1 - 12, XP055972278 [I] 1-15 * Table S2; Table S3 *

DOI:   http://dx.doi.org/10.1186/1472-6750-11-109
by applicantWO2004079326
 US6818395
 US6911345
 WO2006034833
 US2006252077
 US7169560
 US2007070349
 US7220549
 US7226720
 US7279563
 US7282337
 US2011201598
 US8067434
    - FRIEIR et al., PNAS, (19860000), vol. 83, pages 9373 - 9377
    - SHENDURE et al., "Next-generation DNA sequencing", Nature, (20080000), vol. 26, no. 10, doi:10.1038/nbt1486, pages 1135 - 1145, XP002572506

DOI:   http://dx.doi.org/10.1038/nbt1486
    - MARDIS, "The impact of next-generation sequencing technology on genetics", Trends in Genetics, (20070000), vol. 24, no. 3, pages 133 - 141, XP022498431
    - SU et al., "Next-generation sequencing and its applications in molecular diagnostics", Expert Rev Mol Diagn, (20110000), vol. 11, no. 3, doi:10.1586/erm.11.3, pages 333 - 43, XP009505883

DOI:   http://dx.doi.org/10.1586/erm.11.3
    - ZHANG et al., "The impact of next-generation sequencing on genomics", J Genet Genomics, (20110000), vol. 38, no. 3, doi:10.1016/j.jgg.2011.02.003, pages 95 - 109, XP028188028

DOI:   http://dx.doi.org/10.1016/j.jgg.2011.02.003
    - NYREN, P. et al., Anal Biochem, (19930000), vol. 208, page 17175
    - BENTLEY, D. R., Curr Opin Genet Dev, (20060000), vol. 16, pages 545 - 52
    - STRAUSBERG, R. L. et al., Drug Disc Today, (20080000), vol. 13, pages 569 - 77
    - SODA et al., Nature, (20070000), pages 448561 - 6
    - RIKOVA et al., Cell, (20070000), vol. 131, pages 1190 - 1203
    - TAKOUCHI et al., Nature Medicine, (20120000), vol. 18, pages 378 - 81
    - GALKIN et al., Proc Natl Acad Sci USA, (20070000), vol. 104, pages 270 - 275
    - ZOU et al., Cancer Res, (20070000), vol. 67, pages 4408 - 4417
    - HALLBERGPALMER, F1000 Med Reports, (20110000), vol. 3, page 21
    - SAKAMOTO et al., Cancer Cell, (20110000), vol. 19, pages 679 - 690
    - "NCBI Gene", Database accession no. 5979
    - SAMADI et al., Surgery, (20100000), vol. 148, pages 1228 - 36
    - CUCCURU et al., JNCI, (20040000), vol. 13, pages 1006 - 1014
    - AKENO-STUART et al., Cancer Research, (20070000), vol. 67, page 6956
    - GRAZMA et al., J Clin Oncol, (20100000), vol. 28, no. 15s, page 5559
    - MOLOGNI, J Mol Endocrinol, (20060000), vol. 37, pages 199 - 212
    - CALMOMAGNO et al., Journal NCI, (20060000), vol. 98, pages 326 - 334
    - MOLOGNI, Curr Med Chem, (20110000), vol. 18, pages 162 - 175
    - Agnew, Chem. Intl. Ed. Engl., (19940000), vol. 33, pages 183 - 186
 WO2015US12891
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.